Azurity Pharmaceuticals Announces the Availability of JAVADIN(TM) (clonidine hydrochloride) Oral Solution
Azurity Pharmaceuticals Announces the Availability of JAVADIN(TM) (clonidine hydrochloride) Oral Solution First and Only FDA-Approved, Ready-to-Use Clonidine Oral Solution for Hypertension Control in Adult Patients GlobeNewswire December 18, 2025 Woburn, MA, Dec. 18, 2025 (GLOBE NEWSWIRE) — Azurity Pharmaceuticals, Inc. announced today the availability of Javadin(TM) (clonidine hydrochloride) oral solution, the only FDA-approved, immediate-release, ready-to-use […]